Non-psychoactive cannabinoid from which THC and CBD are enzymatically derived in the cannabis plant; early preclinical research suggests antibacterial, anti-inflammatory, and neuroprotective activity, though human trial data remain limited.
Recurrent severe headaches, often with nausea, light sensitivity, and visual disturbances.
Also known as: Cannabigerol
Every published result for this pair, extracted and audited.
Research volume over time for CBG (Cannabigerol) × migraine. Structured outcome extraction (direction, effect size) for this pair is in progress - the full analytics will appear here once audited.
Hand-selected PubMed studies, linked to the originals.
Ordered by strength of evidence, then result direction.
01Medical Cannabis for the Treatment of Migraine in Adults: A Review of the EvidenceOkusanya BO, et al. · Frontiers in neurology · 2022PMID 35711271 ↗02The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo StudiesHenshaw FR, et al. · Cannabis and cannabinoid research · 2021PMID 33998900 ↗03The Use of Cannabinoids in Colitis: A Systematic Review and Meta-AnalysisCouch DG, et al. · Inflammatory bowel diseases · 2018PMID 29562280 ↗04Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid systemMcPartland JM, et al. · PloS one · 2014PMID 24622769 ↗Be the first to share what you noticed with CBG (Cannabigerol) for migraine. How we calculate this.